Publication Information

{'id': 'https://openalex.org/W2740601624', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-1059', 'title': 'Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model', 'display_name': 'Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model', 'publication_year': 2017, 'publication_date': '2017-07-01', 'ids': {'openalex': 'https://openalex.org/W2740601624', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-1059', 'mag': '2740601624'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-1059', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5036367526', 'display_name': 'Diana Llópiz', 'orcid': None}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Diana Llopiz', 'raw_affiliation_strings': ['1CIMA (Centro de Investigación Médica Aplicada), Pamplona, Spain;'], 'affiliations': [{'raw_affiliation_string': '1CIMA (Centro de Investigación Médica Aplicada), Pamplona, Spain;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024726818', 'display_name': 'Marta Ruiz', 'orcid': 'https://orcid.org/0000-0002-8757-0932'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Marta Ruiz', 'raw_affiliation_strings': ['1CIMA (Centro de Investigación Médica Aplicada), Pamplona, Spain;'], 'affiliations': [{'raw_affiliation_string': '1CIMA (Centro de Investigación Médica Aplicada), Pamplona, Spain;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052674512', 'display_name': 'Perrine Pivette', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210143247', 'display_name': 'Onxeo (France)', 'ror': 'https://ror.org/056h1w707', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210143247']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Perrine Pivette', 'raw_affiliation_strings': ['2Onxeo, Paris, France;'], 'affiliations': [{'raw_affiliation_string': '2Onxeo, Paris, France;', 'institution_ids': ['https://openalex.org/I4210143247']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075644538', 'display_name': 'Véronique Trochon-Joseph', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210143247', 'display_name': 'Onxeo (France)', 'ror': 'https://ror.org/056h1w707', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210143247']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Véronique Trochon-Joseph', 'raw_affiliation_strings': ['2Onxeo, Paris, France;'], 'affiliations': [{'raw_affiliation_string': '2Onxeo, Paris, France;', 'institution_ids': ['https://openalex.org/I4210143247']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052773671', 'display_name': 'B. Vasseur', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210143247', 'display_name': 'Onxeo (France)', 'ror': 'https://ror.org/056h1w707', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210143247']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Bérangère Vasseur', 'raw_affiliation_strings': ['2Onxeo, Paris, France;'], 'affiliations': [{'raw_affiliation_string': '2Onxeo, Paris, France;', 'institution_ids': ['https://openalex.org/I4210143247']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5105085029', 'display_name': 'Caroline Lemarchand', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210143247', 'display_name': 'Onxeo (France)', 'ror': 'https://ror.org/056h1w707', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210143247']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Caroline Lemarchand', 'raw_affiliation_strings': ['2Onxeo, Paris, France;'], 'affiliations': [{'raw_affiliation_string': '2Onxeo, Paris, France;', 'institution_ids': ['https://openalex.org/I4210143247']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045006915', 'display_name': 'Graham Dixon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210143247', 'display_name': 'Onxeo (France)', 'ror': 'https://ror.org/056h1w707', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210143247']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Graham Dixon', 'raw_affiliation_strings': ['2Onxeo, Paris, France;'], 'affiliations': [{'raw_affiliation_string': '2Onxeo, Paris, France;', 'institution_ids': ['https://openalex.org/I4210143247']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070973787', 'display_name': 'Pablo Sarobe', 'orcid': 'https://orcid.org/0000-0003-0503-7905'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Pablo Sarobe', 'raw_affiliation_strings': ['1CIMA (Centro de Investigación Médica Aplicada), Pamplona, Spain;'], 'affiliations': [{'raw_affiliation_string': '1CIMA (Centro de Investigación Médica Aplicada), Pamplona, Spain;', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5085766415', 'display_name': 'Bruno Sangro', 'orcid': 'https://orcid.org/0000-0002-4177-6417'}, 'institutions': [{'id': 'https://openalex.org/I4210135003', 'display_name': 'Clinica Universidad de Navarra', 'ror': 'https://ror.org/03phm3r45', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210135003']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Bruno Sangro', 'raw_affiliation_strings': ['3Clínica Universidad de Navarra, Pamplona, Spain.'], 'affiliations': [{'raw_affiliation_string': '3Clínica Universidad de Navarra, Pamplona, Spain.', 'institution_ids': ['https://openalex.org/I4210135003']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.376967, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 64, 'max': 71}, 'biblio': {'volume': '77', 'issue': '13_Supplement', 'first_page': '1059', 'last_page': '1059'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11736', 'display_name': 'Role of Histone Deacetylases in Cellular Regulation', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11736', 'display_name': 'Role of Histone Deacetylases in Cellular Regulation', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Targeted Protein Degradation in Biomedical Research', 'score': 0.9947, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Role of Fibroblast Activation in Cancer Progression', 'score': 0.9852, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/hdac-inhibitors', 'display_name': 'HDAC Inhibitors', 'score': 0.526395}, {'id': 'https://openalex.org/keywords/immune-checkpoint', 'display_name': 'Immune checkpoint', 'score': 0.4303552}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7467258}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5456574}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.53418326}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.50951034}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.49249133}, {'id': 'https://openalex.org/C2780851360', 'wikidata': 'https://www.wikidata.org/wiki/Q21686041', 'display_name': 'Immune checkpoint', 'level': 4, 'score': 0.4303552}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.41084725}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.2794894}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.11156842}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-1059', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4390709402', 'https://openalex.org/W3215438668', 'https://openalex.org/W303802408', 'https://openalex.org/W2961030117', 'https://openalex.org/W2418264232', 'https://openalex.org/W2350538445', 'https://openalex.org/W2345263070', 'https://openalex.org/W2157355069', 'https://openalex.org/W2021792849', 'https://openalex.org/W1968701816'], 'abstract_inverted_index': {'Abstract': [0], 'Introduction': [1], 'Belinostat': [2, 211], 'is': [3, 21, 89], 'an': [4, 32], 'HDAC': [5, 398], 'inhibitor': [6, 221, 393, 399], 'currently': [7], 'marketed': [8], 'in': [9, 26, 41, 106, 116, 130, 140, 150, 238, 242, 245, 291, 295, 310, 340, 345, 353, 394, 401], 'the': [10, 13, 86, 90, 93, 120, 163, 168, 173, 182, 218, 235, 249, 259, 266, 272, 277, 296, 397, 412], 'US': [11], 'for': [12, 255, 307, 415], 'treatment': [14, 251], 'of': [15, 39, 66, 71, 85, 92, 96, 99, 162, 186, 276, 281, 298, 323, 334, 390, 411], 'PTCL.': [16], 'A': [17], 'new': [18, 37], 'oral': [19, 332], 'formulation': [20, 333], 'under': [22], 'development': [23], '(positive': [24], 'PoC': [25], 'preclinical': [27, 406], 'PK': [28], 'study)': [29], 'and': [30, 191, 289, 343, 360], 'provides': [31], 'increase': [33], 'potential': [34], 'to': [35, 118, 155, 158, 177, 230, 315, 326, 355, 361], 'develop': [36], 'indications': [38], 'belinostat': [40, 105, 147, 250, 309, 335, 400], 'combination': [42, 70, 98, 236, 278, 311, 395], 'with': [43, 74, 104, 222, 234, 271, 279, 312, 396], 'other': [44, 75], 'drugs.': [45], 'It': [46], 'has': [47], 'been': [48], 'extensively': [49], 'demonstrated': [50], 'that': [51, 265], 'some': [52], 'anti-tumor': [53, 58, 213, 388], 'agents,': [54], 'besides': [55], 'their': [56], 'direct': [57], 'effect,': [59], 'may': [60, 78], 'induce': [61], 'additional': [62], 'mechanisms': [63], 'involving': [64], 'activation': [65], 'immune': [67, 122, 179, 268], 'responses.': [68], 'Thus,': [69], 'these': [72], 'drugs': [73], 'immunotherapeutic': [76], 'protocols': [77], 'yield': [79], 'improved': [80, 212], 'therapeutic': [81, 94, 214, 274, 317], 'benefits.': [82], 'The': [83, 331], 'objective': [84], 'present': [87], 'study': [88], 'characterization': [91], 'efficacy': [95, 127, 389], 'a': [97, 107, 131, 223, 239, 305, 391, 402], 'checkpoint': [100, 220, 313, 392], 'inhibitors': [101, 314, 329], '(anti-CTLA-4': [102], 'antibodies)': [103], 'murine': [108, 134, 403], 'HCC': [109], 'model.': [110], 'In': [111, 125], 'addition,': [112], 'immunoprofiling': [113], 'was': [114, 128, 167, 204], 'performed': [115, 129], 'order': [117, 354], 'assess': [119], 'associated': [121], 'response.': [123, 318], 'Methods': [124], 'vivo': [126], 'Hepa': [132], '129': [133], 'hepatocellular': [135], 'carcinoma': [136, 405], 'model': [137, 407], 'implanted': [138], 'subcutaneously': [139], 'immune-competent': [141], 'C3H': [142], 'mice': [143, 247], 'using': [144, 308], 'anti-CTLA4': [145, 219], 'alone,': [146], 'alone': [148], 'or': [149], 'combination.': [151, 164], 'Treatments': [152], 'were': [153, 175, 195], 'optimized': [154], 'be': [156], 'able': [157], 'demonstrate': [159], 'positive': [160], 'effect': [161, 275], 'Tumor': [165], 'volume': [166], 'primary': [169], 'endpoint.': [170], 'Samples': [171], 'from': [172], 'spleen': [174], 'taken': [176], 'analyze': [178], 'mechanism': [180], 'mediating': [181], 'antitumor': [183, 285], 'activity.': [184], 'Percent': [185], 'CD4,': [187], 'CD8': [188], 'T': [189, 193, 201, 286, 293], 'cells': [190, 194, 294], 'regulatory': [192, 292], 'determined': [196], 'by': [197, 206, 217], 'flow': [198], 'cytometry.': [199], 'Anti-tumor': [200], 'cell': [202, 287], 'response': [203, 215, 269, 288], 'measured': [205], 'IFN-gamma': [207, 282], 'ELISPOT': [208], 'assay.': [209], 'Results': [210], 'induced': [216], 'significant': [224], 'superior': [225], 'tumor': [226, 243], 'growth': [227, 244], 'inhibition': [228], 'compared': [229], 'control': [231], 'groups.': [232], 'Treatment': [233], 'resulted': [237], 'complete': [240], 'cessation': [241], 'all': [246], 'during': [248], 'period': [252], 'which': [253], 'continued': [254], '1': [256], 'week': [257], 'after': [258], 'final': [260], 'dose.': [261], 'Mechanistic': [262], 'studies': [263, 350], 'showed': [264], 'underlying': [267], 'correlated': [270], 'observed': [273], 'enhancement': [280], 'production': [283], 'as': [284], 'decrease': [290], 'spleens': [297], 'treated': [299], 'animals.': [300], 'Conclusion': [301], 'These': [302], 'results': [303], 'provide': [304], 'rational': [306], 'reinforce': [316], 'Currently': [319], 'only': [320], 'approx.': [321], '20%': [322], 'patients': [324], 'respond': [325], 'check': [327], 'point': [328], 'alone.': [330], 'will': [336], 'allow': [337], 'greater': [338], 'flexibility': [339], 'dosing': [341], 'schedule': [342], 'use': [344], 'multiple': [346], 'clinical': [347], 'situations.': [348], 'Further': [349], 'are': [351], 'ongoing': [352], 'fully': [356], 'characterize': [357], 'this': [358], 'finding': [359], 'facilitate': [362], 'its': [363], 'translation': [364], 'into': [365], 'patients.': [366], 'Citation': [367], 'Format:': [368], 'Diana': [369], 'Llopiz,': [370], 'Marta': [371], 'Ruiz,': [372], 'Perrine': [373], 'Pivette,': [374], 'Véronique': [375], 'Trochon-Joseph,': [376], 'Bérangère': [377], 'Vasseur,': [378], 'Caroline': [379], 'Lemarchand,': [380], 'Graham': [381], 'Dixon,': [382], 'Pablo': [383], 'Sarobe,': [384], 'Bruno': [385], 'Sangro.': [386], 'Enhanced': [387], 'hepato-cellular': [404], '[abstract].': [408], 'In:': [409], 'Proceedings': [410], 'American': [413], 'Association': [414], 'Cancer': [416, 429], 'Research': [417], 'Annual': [418], 'Meeting': [419], '2017;': [420], '2017': [421], 'Apr': [422], '1-5;': [423], 'Washington,': [424], 'DC.': [425], 'Philadelphia': [426], '(PA):': [427], 'AACR;': [428], 'Res': [430], '2017;77(13': [431], 'Suppl):Abstract': [432], 'nr': [433], '1059.': [434], 'doi:10.1158/1538-7445.AM2017-1059': [435]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2740601624', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}], 'updated_date': '2024-09-25T20:40:31.300866', 'created_date': '2017-08-08'}